Ruthenium Complexes With Piplartine Cause Apoptosis Through MAPK Signaling by a P53-Dependent Pathway in Human Colon Carcinoma Cells and Inhibit Tumor Development in a Xenograft Model
Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2019.00582
Full Text
Open PDFAbstract
Available in full text
Date
July 3, 2019
Authors
Publisher
Frontiers Media SA